Results from a Phase 1/2 clinical trial indicate that CRISPR gene-editing has enhanced the vision of individuals with inherited blindness, offering promising prospects for patients and suggesting broader applications of CRISPR in human therapeutics.Leber Congenital Amaurosis (LCA) is a rare disorder affecting approximately one in every 40,000 newborns. Individuals with LCA carry a genetic...
In the initial comprehensive study conducted on monkeys, it was discovered that CRISPR does not induce unintended off-target mutations. Credit : galitskaya/Depositphotos.As the first human trials utilizing the potentially groundbreaking CRISPR gene editing technique are set to begin in the UK and the US, there are lingering concerns regarding the overall safety of this...
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |